Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards

California voters recently approved $3 billion over 10 years for public funding of stem cell research through the California Institute for Regenerative Medicine (CIRM). Geoffrey Lomax and colleagues discuss the principles that guided the CIRM regulations.

Saved in:
Bibliographic Details
Published in:PLoS medicine 2007-05, Vol.4 (5), p.e114-e114
Main Authors: Lomax, Geoffrey P, Hall, Zach W, Lo, Bernard
Format: Article
Language:English
Subjects:
Academies and Institutes - ethics
Academies and Institutes - legislation & jurisprudence
Academies and Institutes - standards
Best practice
California
Embryo Research - ethics
Embryo Research - legislation & jurisprudence
Embryonic Stem Cells
Embryos
Ethical aspects
Ethics
Ethics Committees, Research - ethics
Ethics Committees, Research - legislation & jurisprudence
Ethics Committees, Research - standards
Funding
Government finance
Guideline Adherence - standards
Health Policy
Humans
Informed consent
Laws, regulations and rules
Medical research
Medicine, Experimental
Meetings
Non-Clinical Medicine
Patients
Policy Forum
Regenerative medicine
Research Methods
Science Policy
Stem cell research
Stem cells
Voters
Working groups
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:California voters recently approved $3 billion over 10 years for public funding of stem cell research through the California Institute for Regenerative Medicine (CIRM). Geoffrey Lomax and colleagues discuss the principles that guided the CIRM regulations.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.0040114